▁Introduction 10.375
: 6.515625
<0x0A> 3.95703125
Bre 8.6171875
ast 2.44921875
▁cancer 1.7080078125
▁is 0.7373046875
▁a 1.525390625
▁pre 5.98046875
val 0.283447265625
ent 0.01116943359375
▁and 2.435546875
▁concerning 6.42578125
▁disease 0.79296875
▁affect 3.044921875
ing 0.0023174285888671875
▁millions 2.591796875
▁of 0.2237548828125
▁women 0.59765625
▁world 0.974609375
wide 0.02203369140625
. 0.45068359375
▁It 2.27734375
▁is 0.40576171875
▁cru 6.53515625
cial 0.0272064208984375
▁to 0.337890625
▁understand 2.09375
▁the 0.5810546875
▁critical 6.65234375
▁factors 2.6875
▁that 0.939453125
▁contribute 1.9296875
▁to 0.0271453857421875
▁its 2.484375
▁development 1.0400390625
, 1.76953125
▁including 2.97265625
▁her 4.97265625
ed 1.455078125
ity 0.00586700439453125
, 0.35546875
▁dise 10.0
ases 0.003505706787109375
▁of 3.201171875
▁the 0.5859375
▁m 6.0390625
amm 0.042449951171875
ary 0.00458526611328125
▁g 0.0792236328125
lands 1.4541015625
, 0.254638671875
▁and 1.0400390625
▁h 2.49609375
orm 0.0007004737854003906
onal 0.476318359375
▁factors 1.6904296875
. 0.26171875
▁Det 7.2421875
ect 3.388671875
ing 0.032989501953125
▁early 2.69921875
▁met 6.734375
ast 0.033233642578125
asis 1.6572265625
▁and 1.7744140625
▁assess 5.54296875
ing 0.021759033203125
▁the 0.85107421875
▁ag 5.0
gress 0.007511138916015625
iveness 0.135498046875
▁of 0.10650634765625
▁the 1.15234375
▁cancer 2.810546875
▁type 8.7109375
▁play 4.32421875
▁a 0.7099609375
▁p 2.458984375
iv 7.665157318115234e-05
otal 9.822845458984375e-05
▁role 0.0213165283203125
▁in 0.0513916015625
▁gu 4.04296875
iding 0.0017061233520507812
▁treatment 1.220703125
▁dec 1.46484375
isions 4.4465065002441406e-05
▁and 1.775390625
▁impro 1.62890625
ving 0.0009899139404296875
▁patient 1.3916015625
▁out 0.498046875
comes 0.004947662353515625
. 0.0589599609375
<0x0A> 1.814453125
Body 9.46875
: 4.5859375
<0x0A> 2.341796875
I 5.625
. 2.587890625
▁Her 4.45703125
ed 0.240234375
ity 0.00482177734375
▁as 7.625
▁a 0.27099609375
▁Crit 3.66015625
ical 0.0038967132568359375
▁F 0.0572509765625
actor 6.842613220214844e-05
: 2.908203125
<0x0A> 0.1385498046875
H 1.826171875
ered 0.029205322265625
ity 0.0020694732666015625
▁is 0.92919921875
▁a 1.2236328125
▁significant 2.865234375
▁contrib 1.7841796875
utor 0.619140625
▁to 0.08099365234375
▁the 0.85888671875
▁development 0.6025390625
▁of 0.0958251953125
▁breast 0.34423828125
▁cancer 0.0252532958984375
. 0.5244140625
▁Gen 3.33984375
etic 0.28369140625
▁mut 2.015625
ations 0.046783447265625
, 2.14453125
▁such 1.7021484375
▁as 0.0009489059448242188
▁in 5.33984375
▁the 1.3671875
▁BR 0.38916015625
CA 0.002002716064453125
1 0.320068359375
▁and 0.330078125
▁BR 0.025146484375
CA 0.0029354095458984375
2 0.005054473876953125
▁gen 0.18505859375
es 0.0017833709716796875
, 0.0869140625
▁increase 1.908203125
▁the 0.319580078125
▁sus 4.421875
cept 2.384185791015625e-05
ibility 0.0005030632019042969
▁to 0.477294921875
▁the 2.486328125
▁disease 0.8076171875
▁substantial 9.2109375
ly 0.00014865398406982422
. 0.1602783203125
▁Ind 5.484375
ividual 0.0215606689453125
s 0.06512451171875
▁with 0.65185546875
▁a 0.85888671875
▁family 1.400390625
▁history 0.0225982666015625
▁of 0.0328369140625
▁breast 0.2359619140625
▁cancer 0.10577392578125
▁have 1.74609375
▁a 0.475341796875
▁higher 1.98046875
▁risk 0.26806640625
▁of 0.1043701171875
▁developing 0.177490234375
▁the 0.389404296875
▁disease 0.11712646484375
▁due 4.9140625
▁to 0.0028533935546875
▁inherited 2.59375
▁gen 1.125
etic 0.477294921875
▁pre 3.1953125
dis 0.002750396728515625
pos 1.8837890625
itions 0.0269317626953125
. 0.485107421875
▁Under 7.8359375
standing 0.06365966796875
▁the 0.44384765625
▁role 2.751953125
▁of 0.1544189453125
▁her 1.9833984375
ed 0.3466796875
ity 0.0013790130615234375
▁in 0.314453125
▁breast 0.841796875
▁cancer 0.01611328125
▁development 1.5244140625
▁can 2.09765625
▁help 0.77001953125
▁identify 2.2109375
▁high 3.521484375
- 0.04736328125
ris 0.001556396484375
k 4.088878631591797e-05
▁individuals 0.85986328125
▁for 2.72265625
▁pro 4.59375
active 2.234375
▁screen 1.1298828125
ing 0.11309814453125
▁and 0.7744140625
▁prevent 2.46484375
ive 0.72802734375
▁measures 1.1689453125
. 0.2490234375
<0x0A> 0.212890625
II 1.12890625
. 0.0034084320068359375
▁D 0.57275390625
ise 0.014617919921875
ases 0.0189361572265625
▁of 0.0125274658203125
▁the 0.04278564453125
▁M 0.020233154296875
amm 0.0005049705505371094
ary 6.747245788574219e-05
▁G 0.00579071044921875
lands 0.07330322265625
: 0.55126953125
<0x0A> 0.003276824951171875
C 4.78515625
ertain 1.2705078125
▁dise 0.57373046875
ases 5.412101745605469e-05
▁affect 3.69140625
ing 0.796875
▁the 0.08404541015625
▁m 0.17822265625
amm 0.0006289482116699219
ary 0.00014972686767578125
▁g 0.0087127685546875
lands 0.1048583984375
▁can 1.390625
▁increase 1.515625
▁the 0.21044921875
▁risk 0.1434326171875
▁of 0.050445556640625
▁breast 0.75634765625
▁cancer 0.00408935546875
. 0.7431640625
▁For 2.50390625
▁instance 1.33984375
, 0.0012788772583007812
▁at 5.765625
yp 0.564453125
ical 0.01528167724609375
▁hyper 0.1263427734375
pl 0.006683349609375
asia 0.030914306640625
, 0.94384765625
▁a 2.16796875
▁pro 6.171875
l 0.01898193359375
ifer 0.0005526542663574219
ative 0.332763671875
▁condition 1.6884765625
▁character 3.416015625
ized 0.01483154296875
▁by 0.002490997314453125
▁ab 2.78515625
normal 0.0157318115234375
▁cell 1.267578125
▁growth 0.299072265625
▁in 1.7373046875
▁the 0.0811767578125
▁breast 1.025390625
▁t 2.140625
issue 0.06298828125
, 0.05157470703125
▁is 0.681640625
▁associated 2.140625
▁with 0.0012340545654296875
▁a 1.49609375
▁higher 0.93359375
▁risk 0.2388916015625
▁of 0.027130126953125
▁developing 0.71337890625
▁cancer 2.521484375
. 0.2919921875
▁Other 1.9912109375
▁ben 7.19140625
ign 1.9073486328125e-05
▁conditions 1.34765625
, 0.5703125
▁like 3.615234375
▁pap 5.4296875
ill 0.0130157470703125
omas 2.201171875
▁and 1.1220703125
▁fib 1.451171875
ro 0.15185546875
aden 0.09735107421875
omas 0.08453369140625
, 0.02471923828125
▁also 1.8193359375
▁contribute 2.73828125
▁to 0.058441162109375
▁an 3.166015625
▁increased 0.17041015625
▁risk 0.2939453125
. 2.751953125
▁It 4.53515625
▁is 0.08392333984375
▁important 0.6865234375
▁for 2.419921875
▁health 2.001953125
care 0.1822509765625
▁profession 0.90380859375
als 2.2649765014648438e-06
▁to 0.0460205078125
▁evaluate 4.6328125
▁these 1.7509765625
▁pre 5.71484375
- 1.376953125
can 0.630859375
cer 0.005229949951171875
ous 0.014068603515625
▁conditions 0.445068359375
▁and 1.80859375
▁closely 6.58203125
▁monitor 0.0394287109375
▁patients 1.544921875
▁to 1.9951171875
▁detect 0.96533203125
▁any 1.94140625
▁m 3.3046875
align 0.017181396484375
ant 0.24609375
▁transformation 3.29296875
. 0.40478515625
<0x0A> 0.0968017578125
III 0.246826171875
. 0.0022487640380859375
▁H 0.0875244140625
orm 2.2411346435546875e-05
onal 0.11541748046875
▁Fact 0.14599609375
ors 0.00010597705841064453
: 0.220703125
<0x0A> 0.0019073486328125
H 1.130859375
orm 0.0030727386474609375
onal 0.5166015625
▁factors 0.2208251953125
, 1.6494140625
▁especially 4.22265625
▁est 0.66064453125
ro 0.10394287109375
gen 5.1856040954589844e-05
, 1.0625
▁play 0.78515625
▁a 0.194580078125
▁critical 1.5634765625
▁role 0.004779815673828125
▁in 0.0009832382202148438
▁breast 1.431640625
▁cancer 0.08221435546875
▁development 0.1251220703125
. 0.1441650390625
▁Pro 5.1015625
long 1.048828125
ed 0.0004525184631347656
▁expos 0.3994140625
ure 0.0019426345825195312
▁to 0.035369873046875
▁est 0.421142578125
ro 0.0845947265625
gen 0.0001289844512939453
▁without 8.640625
▁the 1.5048828125
▁counter 4.5703125
bal 0.65478515625
ancing 0.330322265625
▁effects 1.16796875
▁of 0.01375579833984375
▁pro 0.85546875
g 0.11480712890625
ester 0.00010156631469726562
one 0.001117706298828125
▁can 1.2939453125
▁increase 1.85546875
▁the 0.156494140625
▁risk 0.06219482421875
. 4.47265625
▁Fact 6.60546875
ors 0.0003883838653564453
▁contrib 5.80859375
uting 0.0002944469451904297
▁to 0.01016998291015625
▁increased 4.1484375
▁est 0.2178955078125
ro 0.0060272216796875
gen 1.1205673217773438e-05
▁expos 2.28125
ure 0.0013294219970703125
▁include 0.369873046875
▁early 3.98828125
▁men 0.5771484375
ar 0.17724609375
che 0.00016880035400390625
, 0.2457275390625
▁late 3.578125
▁men 0.2186279296875
op 0.00618743896484375
ause 0.0021266937255859375
, 0.0193939208984375
▁n 9.7734375
ul 0.15771484375
li 0.020172119140625
par 0.01525115966796875
ity 0.036865234375
, 0.0264129638671875
▁and 0.6689453125
▁h 3.10546875
orm 0.41650390625
one 0.175048828125
▁replacement 0.358154296875
▁ther 0.01035308837890625
apy 0.047149658203125
. 0.41845703125
▁Under 5.33984375
standing 0.005069732666015625
▁the 0.3525390625
▁impact 2.537109375
▁of 0.036407470703125
▁h 0.9140625
orm 2.09808349609375e-05
onal 0.488525390625
▁im 3.08203125
bal 0.00020122528076171875
ances 0.41845703125
▁on 0.583984375
▁breast 0.6865234375
▁cancer 0.07940673828125
▁can 2.2890625
▁aid 3.53125
▁in 0.1651611328125
▁prevent 2.64453125
ive 0.873046875
▁strateg 3.005859375
ies 6.306171417236328e-05
, 2.232421875
▁such 0.658203125
▁as 0.0010690689086914062
▁h 2.162109375
orm 0.0197296142578125
one 0.09417724609375
- 1.6044921875
mod 4.5703125
ulating 1.6435546875
▁medic 1.48828125
ations 0.1339111328125
▁or 2.822265625
▁l 3.55859375
ifest 0.0014410018920898438
yle 0.0007119178771972656
▁modifications 1.171875
. 0.475830078125
<0x0A> 0.03271484375
IV 0.60205078125
. 0.001873016357421875
▁Import 7.8671875
ance 0.79345703125
▁of 0.07635498046875
▁Early 1.4326171875
▁Met 6.98046875
ast 0.0007328987121582031
asis 0.04095458984375
▁D 0.65380859375
ete 0.0003445148468017578
ction 0.0004703998565673828
: 0.1300048828125
<0x0A> 0.0012254714965820312
E 0.8740234375
ar 0.0034008026123046875
ly 0.001117706298828125
▁detection 0.61865234375
▁of 0.259521484375
▁met 1.0625
ast 0.00010335445404052734
asis 0.78955078125
▁in 3.365234375
▁breast 0.3740234375
▁cancer 0.01727294921875
▁is 0.4375
▁cru 1.2158203125
cial 0.0005183219909667969
▁for 0.9296875
▁improved 3.66796875
▁pro 2.771484375
gn 0.0014848709106445312
osis 0.057220458984375
▁and 0.4111328125
▁treatment 1.740234375
▁out 0.70556640625
comes 0.0001760721206665039
. 0.0289764404296875
▁Met 2.26953125
ast 0.0017671585083007812
asis 0.38671875
▁refers 1.8994140625
▁to 0.0005087852478027344
▁the 0.0810546875
▁spread 0.460693359375
▁of 0.021759033203125
▁cancer 0.171630859375
▁from 1.4599609375
▁the 0.48779296875
▁breast 3.890625
▁to 0.409423828125
▁distant 2.2734375
▁org 0.6708984375
ans 5.125999450683594e-06
▁or 1.697265625
▁t 0.8955078125
issues 0.0247344970703125
, 1.03125
▁such 1.4208984375
▁as 0.0002899169921875
▁the 0.14892578125
▁l 0.71484375
ungs 0.0478515625
, 0.479736328125
▁b 2.53125
ones 0.2529296875
, 0.004421234130859375
▁or 1.626953125
▁li 0.857421875
ver 0.0012111663818359375
. 0.060302734375
▁Det 3.349609375
ect 0.037109375
ing 0.0006937980651855469
▁met 0.70849609375
ast 5.8650970458984375e-05
atic 1.60546875
▁breast 1.5869140625
▁cancer 0.0299530029296875
▁at 1.05859375
▁an 0.145263671875
▁early 0.050384521484375
▁stage 0.00829315185546875
▁allows 1.7314453125
▁for 0.74462890625
▁more 1.59765625
▁effective 0.8134765625
▁treatment 0.360595703125
▁inter 4.78515625
vent 0.0780029296875
ions 7.3909759521484375e-06
▁and 0.998046875
▁potentially 5.61328125
▁cur 4.15234375
ative 0.137939453125
▁options 1.943359375
. 0.177734375
▁Reg 7.3046875
ular 0.0936279296875
▁screen 0.80712890625
ing 0.317626953125
, 2.615234375
▁including 1.1201171875
▁imag 3.125
ing 0.0019445419311523438
▁techniques 3.46484375
▁( 5.16015625
such 0.91259765625
▁as 0.0005993843078613281
▁m 1.0810546875
amm 0.0018482208251953125
ography 0.1043701171875
, 2.361328125
▁ul 0.65771484375
tras 0.080078125
ound 0.0089874267578125
, 0.02752685546875
▁or 1.71875
▁M 1.240234375
RI 0.006214141845703125
) 0.60498046875
▁and 0.1964111328125
▁blood 1.7236328125
▁tests 0.32763671875
▁( 2.1328125
like 3.46875
▁meas 6.53515625
uring 0.0023345947265625
▁tum 2.857421875
or 0.035400390625
▁markers 0.1917724609375
), 0.50634765625
▁helps 3.69140625
▁identify 1.0966796875
▁any 4.5234375
▁signs 2.4765625
▁of 0.2359619140625
▁distant 5.80859375
▁spread 1.033203125
. 1.4208984375
<0x0A> 0.72998046875
V 1.0908203125
. 0.00933074951171875
▁Method 6.5625
s 0.1861572265625
▁to 1.6591796875
▁Det 2.064453125
erm 2.9609375
ine 0.004726409912109375
▁Can 3.736328125
cer 0.0030956268310546875
▁Ag 1.0908203125
gress 0.0318603515625
iveness 0.0035190582275390625
: 0.05426025390625
<0x0A> 0.0020198822021484375
Ass 4.9140625
ess 0.0010738372802734375
ing 0.056304931640625
▁the 0.29541015625
▁ag 0.40478515625
gress 0.0010223388671875
iveness 0.003955841064453125
▁of 0.0179901123046875
▁breast 0.8984375
▁cancer 0.00675201416015625
▁is 0.7421875
▁cru 1.623046875
cial 0.0005445480346679688
▁for 0.404541015625
▁tail 4.421875
oring 0.11956787109375
▁treatment 0.51806640625
▁plans 2.8046875
. 2.279296875
▁Several 3.609375
▁methods 1.6640625
▁are 1.185546875
▁util 5.3203125
ized 0.00140380859375
▁to 0.201171875
▁determine 1.173828125
▁the 0.8447265625
▁ag 1.275390625
gress 0.0009093284606933594
iveness 0.00894927978515625
, 3.564453125
▁including 0.20166015625
: 5.64453125
<0x0A> 0.203125
a 6.05078125
) 1.33203125
▁Hist 2.25
op 0.358642578125
ath 0.0013370513916015625
ological 0.83740234375
▁exam 2.162109375
ination 0.09344482421875
: 0.75830078125
▁This 2.04296875
▁involves 0.962890625
▁analyz 3.98828125
ing 2.2172927856445312e-05
▁a 3.560546875
▁tum 2.22265625
or 0.004337310791015625
▁sample 0.83642578125
▁obtained 4.6796875
▁through 1.99609375
▁bi 1.80078125
ops 0.00013387203216552734
y 0.00911712646484375
, 2.83203125
▁which 1.9482421875
▁provides 2.71484375
▁information 1.4267578125
▁about 0.64404296875
▁its 2.33203125
▁size 2.513671875
, 0.125732421875
▁grade 3.615234375
, 0.09149169921875
▁presence 4.7890625
▁of 0.22265625
▁h 6.3046875
orm 0.0258026123046875
one 0.2139892578125
▁re 0.056060791015625
cept 0.070068359375
ors 0.0013704299926757812
▁( 3.43359375
estro 1.6259765625
gen 3.8743019104003906e-05
▁and 0.9658203125
▁pro 0.275634765625
g 0.0034332275390625
ester 9.5367431640625e-06
one 0.00140380859375
▁re 1.1669921875
cept 0.036956787109375
ors 2.205371856689453e-05
), 0.1573486328125
▁and 0.400146484375
▁human 9.3984375
▁e 0.0570068359375
pid 0.0021152496337890625
erm 0.006320953369140625
al 0.002300262451171875
▁growth 0.005115509033203125
▁factor 0.006473541259765625
▁re 0.1217041015625
ceptor 0.153564453125
▁ 0.379638671875
2 0.002262115478515625
▁( 0.174560546875
HER 0.0193023681640625
2 0.1077880859375
) 0.220458984375
▁expression 1.1689453125
. 0.259521484375
<0x0A> 0.53125
b 0.022430419921875
) 0.0007715225219726562
▁M 2.08203125
ole 0.03515625
cular 0.0004916191101074219
▁profil 1.5478515625
ing 0.00012826919555664062
: 0.07611083984375
▁Te 8.421875
chni 0.00450897216796875
ques 0.0011653900146484375
▁like 1.16015625
▁gene 1.7236328125
▁expression 0.34130859375
▁profil 0.48193359375
ing 2.2292137145996094e-05
, 1.2451171875
▁including 4.15625
▁the 2.94140625
▁On 7.79296875
cot 0.7021484375
ype 0.0155181884765625
▁D 0.1614990234375
X 0.192626953125
▁and 1.830078125
▁Mam 4.84375
map 0.82080078125
r 0.04266357421875
int 0.037628173828125
▁tests 1.0390625
, 0.07025146484375
▁analyze 3.705078125
▁the 0.9375
▁expression 1.6484375
▁pattern 3.998046875
▁of 0.028167724609375
▁multiple 4.3046875
▁gen 0.2225341796875
es 0.0188751220703125
▁in 1.4580078125
▁the 1.66796875
▁tum 0.2135009765625
or 0.005191802978515625
. 2.052734375
▁These 1.908203125
▁tests 1.3056640625
▁provide 1.98046875
▁additional 3.875
▁information 0.314208984375
▁about 0.3115234375
▁the 0.4189453125
▁lik 5.56640625
elihood 0.0082855224609375
▁of 0.0206756591796875
▁rec 2.515625
urrence 0.0089111328125
▁and 0.580078125
▁the 1.8984375
▁potential 1.732421875
▁benefit 4.19921875
▁of 0.08367919921875
▁specific 3.099609375
▁ther 1.7099609375
ap 0.0257720947265625
ies 1.7762184143066406e-05
. 0.2166748046875
<0x0A> 0.03204345703125
Con 7.36328125
clusion 0.3046875
: 0.2186279296875
<0x0A> 6.0078125
Recogn 8.375
izing 0.08209228515625
▁and 2.857421875
▁understanding 1.826171875
▁the 0.1199951171875
▁critical 0.7802734375
▁factors 0.09051513671875
▁contrib 2.197265625
uting 0.00012743473052978516
▁to 0.00098419189453125
▁breast 0.73974609375
▁cancer 0.0019073486328125
▁development 0.2227783203125
, 1.8232421875
▁such 1.51171875
▁as 0.0012416839599609375
▁her 0.26611328125
ed 0.048492431640625
ity 0.00011849403381347656
, 0.095703125
▁dise 0.54150390625
ases 8.26120376586914e-05
▁of 0.01412200927734375
▁the 0.01157379150390625
▁m 0.0023517608642578125
amm 0.0010385513305664062
ary 0.00025153160095214844
▁g 0.0017251968383789062
lands 0.017547607421875
, 0.016387939453125
▁and 0.053436279296875
▁h 0.0192718505859375
orm 3.5762786865234375e-07
onal 0.08001708984375
▁factors 0.0364990234375
, 0.0305938720703125
▁is 0.85546875
▁cru 1.2568359375
cial 0.0002086162567138672
▁for 0.1920166015625
▁early 3.458984375
▁detection 0.333984375
▁and 0.46875
▁effective 1.7646484375
▁prevent 2.580078125
ion 0.9306640625
▁strateg 1.0185546875
ies 2.86102294921875e-06
. 0.06939697265625
▁Det 2.705078125
ect 0.052215576171875
ing 0.00022208690643310547
▁early 1.0380859375
▁met 0.02984619140625
ast 8.45193862915039e-05
asis 0.166015625
▁and 0.1864013671875
▁accur 5.6796875
ately 5.841255187988281e-06
▁assess 0.2235107421875
ing 6.818771362304688e-05
▁the 0.1468505859375
▁ag 0.08062744140625
gress 0.00022399425506591797
iveness 0.001148223876953125
▁of 0.0132293701171875
▁breast 2.025390625
▁cancer 0.0079345703125
▁aid 6.0390625
▁in 0.02923583984375
▁personal 6.36328125
izing 0.3193359375
▁treatment 0.2032470703125
▁plans 1.478515625
▁and 0.5205078125
▁impro 0.2509765625
ving 0.00011348724365234375
▁patient 0.35791015625
▁out 0.013946533203125
comes 0.0002493858337402344
. 0.01336669921875
▁Through 5.00390625
▁on 4.9609375
going 0.0232696533203125
▁research 0.564453125
▁and 1.1591796875
▁aw 4.34765625
aren 9.226799011230469e-05
ess 2.0742416381835938e-05
, 1.390625
▁we 1.1240234375
▁can 0.230224609375
▁continue 1.7607421875
▁to 0.10882568359375
▁advance 2.076171875
▁in 3.791015625
▁our 0.95068359375
▁understanding 0.310546875
▁of 0.06353759765625
▁breast 1.037109375
▁cancer 0.010467529296875
▁and 0.59375
▁improve 2.060546875
▁the 1.40234375
▁lives 1.1337890625
▁of 0.0110626220703125
▁those 0.54736328125
▁affected 0.1966552734375
▁by 1.21484375
▁it 1.2412109375
. 0.0234527587890625
